CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120

Open Access

Peer-reviewed

Research Article

CB₂ Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120

Shuxian Hu,

Affiliation Center for Infectious Diseases and Microbiology Translational Research, Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America
⨯
Wen S. Sheng,

Affiliation Center for Infectious Diseases and Microbiology Translational Research, Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America
⨯
R. Bryan Rock

* E-mail: rockx012@umn.edu

Affiliation Center for Infectious Diseases and Microbiology Translational Research, Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America
⨯

x

Powered by Altmetric

Questions or concerns about usage data? Please let us know.

Print

Microglial cells
Is the Subject Area "Microglial cells" applicable to this article?

Thanks for your feedback.
Dopaminergics
Is the Subject Area "Dopaminergics" applicable to this article?

Thanks for your feedback.
Cannabinoids
Is the Subject Area "Cannabinoids" applicable to this article?

Thanks for your feedback.
Neurons
Is the Subject Area "Neurons" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
HIV-1
Is the Subject Area "HIV-1" applicable to this article?

Thanks for your feedback.
Oxidative damage
Is the Subject Area "Oxidative damage" applicable to this article?

Thanks for your feedback.
Neuronal death
Is the Subject Area "Neuronal death" applicable to this article?

Thanks for your feedback.